DDL 2022

December 7-9, 2022 | Edinburgh, Scotland

Proveris will sponsor this year’s Drug Delivery to The Lungs (DDL) conference which will be held December 7-9. Attendees to our exhibit will be able to explore new tools for spray characterization, studies for predictive in vitro / in vivo correlation, and precision automated actuation technology for through-life testing.

If you would like to learn more and schedule a meeting with us,
email us at contactus@proveris.com.

Drug Delivery to the Lungs (DDL) is an annual conference covering all aspects of respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts. It offers a venue for lectures, posters and exhibitions.

IDDA 2022

TBD | China

Proveris Scientific’s partner in China, Ruty Li of Quantaflux, will attend the Inhalation Drug Delivery Association Conference (IDDA). He will be at the Proveris table in the exhibit area and will give a scientific presentation on behalf of Proveris.

If you would like to learn more and schedule a meeting with him, email us
at contactus@proveris.com.

The Inhalation Drug Delivery Association Conference brings together well-known academics, experts and scholars from China and around the world. The conference provides a venue for the industry to exchange information, academic views, technologies and interactive communication on applications, laws and regulations, clinical research, market conditions.

RDD 2022

May 1-5, 2022 | Florida, USA

Proveris is an exhibitor and workshop presenter at this year’s Respiratory Drug Delivery, RDD 2022, which will be held in-person from May 1-5 and as a virtual conference from April 25-June 30.

Our in-person workshop scheduled for Tuesday, May 3, will last 60 minutes, and will repeated three times during the day to ensure conference delegates have the greatest opportunity to attend. Workshop presenters are Lynn Jordan, Senior Applications Manager, and Ian Flaherty, Senior Product Manager.

The workshop entitled, ‘Automated pMDI Handling for Dose Content Uniformity Testing and Aerodynamic Particle Size Distribution,’ will cover a new platform from Proveris Scientific to automate the pMDI shaking, priming, dose collection, and fire down for Dose Content Uniformity (DCU) and Aerodynamic Particle Size Distribution (APSD). Currently DCU and APSD are primarily manual processes, subject to the variability. The workshop will review testing requirements and compare the results of the manual versus automated process using the Proveris Kinaero CxTM Automated pMDI Collection System. Comparison data from both processes will be reviewed for several pMDI products, highlighting the improved performance that can be achieved by holding the testing variables consistent with the automated method. In addition, the discussion will cover the parameters available for automated mixing, an integral part of any suspension based pMDI. The workshop will conclude with a product demonstration for DCU sample preparation using the Kinaero Cx pMDI Collection System.

The exhibition session runs from 11:30 AM–2:20 PM and to 5:00 PM-7:00 PM on Monday, May 2 and on Tuesday, May 3. The Proveris team attending the conference are Ben Okorodudu, Senior Vice President of Sales, Lee Dalton, Sales Director for the Americas, Lynn Jordan, Senior Applications Manager, and Ian Flaherty, Senior Product Manager. Visit with them at the Proveris table. Schedule a private meeting or product demonstration of our new Kinaero Cx pMDI Collection System.

If you would like to learn more and schedule a meeting or product demo with us, email us at contactus@proveris.com.

Respiratory Drug Delivery, RDD®, is an international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. It provides a venue for expert speakers to cover topics including new therapeutic opportunities, drug delivery technologies, regulatory science, and novel in vitro, in vivo and clinical testing methods.